Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1957Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG.NO:IF0221001 | - |
| dc.date.accessioned | 2025-09-23T11:43:25Z | - |
| dc.date.available | 2025-09-23T11:43:25Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1957 | - |
| dc.description.abstract | ABTRACT BACKGROUND: Pain is a multifaceted sensation comprising both physiological and psychological reactions triggered by a harmful stimulus. It is a most common post operative sequalae associated with third molar surgery. This causes discomfort to patient and causes emotional and functional deficit. Non steroidal anti inflammatory drugs have been used to manage the post operative pain. NSAIDs have various complications and to eliminate that long acting anaesthetic drugs can be used alternatively. Lo cal drug delivery reduces systemic toxicity by sustained release of the drug to the target site. OBJECTIVE: To assess the efficacy of 2% Lignocaine HCL and 0.5% Bupivacaine HCL soaked in Absorbable gelatin sponge in reducing post operative pain associated with impacted mandibular third molar surgery. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Impacted mandibular third molar, Bupivacaine , Lignocaine, Absorbable Gelatin Sponge, Post operative pain. | en_US |
| dc.title | Comparative evaluation of efficacy of Lignocaine HCL and Bupivacaine HCL used as a local drug delivery system for pain control after impacted mandibular third molar surgery: A single blinded randomized controlled trial | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Oral & Maxillofacial Surgery | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IF0221001.pdf | 8.1 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.